Jpmorgan Chase & CO Codexis, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Codexis, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 31,468 shares of CDXS stock, worth $123,669. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,468

Previous 31,172 0.95%

Holding current value

$123,669

Previous $96,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$2.62 - $3.71 $775 - $1,098	296 Added 0.95%	31,468 $96,000
Q2 2024 Aug 12, 2024	SELL	$2.65 - $3.92 $32,441 - $47,988	-12,242 Reduced 28.2%	31,172 $96,000
Q1 2024 May 10, 2024	SELL	$2.59 - $4.65 $165,208 - $296,609	-63,787 Reduced 59.5%	43,414 $151,000
Q4 2023 Feb 12, 2024	SELL	$1.54 - $3.37 $270,565 - $592,082	-175,692 Reduced 62.11%	107,201 $326,000
Q3 2023 Nov 14, 2023	BUY	$1.5 - $3.75 $106,206 - $265,515	70,804 Added 33.38%	282,893 $534,000
Q2 2023 Aug 11, 2023	BUY	$2.21 - $4.43 $162,061 - $324,856	73,331 Added 52.85%	212,089 $593,000
Q1 2023 May 18, 2023	BUY	$3.81 - $6.76 $178,669 - $317,010	46,895 Added 51.05%	138,758 $574,000
Q1 2023 May 11, 2023	SELL	$3.81 - $6.76 $16,123 - $28,608	-4,232 Reduced 4.4%	91,863 $380,000
Q4 2022 Feb 13, 2023	BUY	$4.26 - $6.84 $158,288 - $254,153	37,157 Added 63.04%	96,095 $448,000
Q3 2022 Nov 14, 2022	SELL	$6.06 - $12.86 $3,211 - $6,815	-530 Reduced 0.89%	58,938 $357,000
Q2 2022 Aug 11, 2022	BUY	$8.35 - $21.89 $61,389 - $160,935	7,352 Added 14.11%	59,468 $622,000
Q1 2022 May 11, 2022	BUY	$16.97 - $31.93 $150,523 - $283,219	8,870 Added 20.51%	52,116 $1.08 Million
Q4 2021 Feb 10, 2022	BUY	$25.61 - $41.78 $412,628 - $673,159	16,112 Added 59.38%	43,246 $1.35 Million
Q3 2021 Nov 12, 2021	BUY	$19.65 - $27.99 $533,183 - $759,480	27,134 New	27,134 $631,000

Others Institutions Holding CDXS

# of Institutions

125

Shares Held

59.9M

Call Options Held

25.9K

Put Options Held

20.1K

View Full List

About CODEXIS, INC.

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $257M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

More about CDXS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Codexis, Inc. Transaction History